Board of Directors
Board of Directors
Chairman of the Board
Life science executive with broad experience from both pharma and medtech industry. 20 years of experience from the position as the CEO and Board member of companies in the start-up phase. Currently Chairman of three listed companies; Monivent, Ziccum and Lipidor and the private company Emollivet. Also a board member of the private company Phargentis AB.
Shareholding in Monivent: 150 000 shares
Co-founder / Board Member
Pontus is a pediatrician and neonatologist who has always had a burning interest in pediatric emergency medicine and also educating others. With his long history of emergency neonatology focusing on respiration and educational experience, Pontus has identified the needs that exist concerning ventilation and how those can be solved. This has led him to the idea of a tool to optimize ventilation in resuscitation of newborns.
Shareholding in Monivent: 440 728 shares
Clas is a market economist who has held senior executive positions in several medtech companies including Gambro and HemoCue in Sweden; Diatek Medical Technologies, Block Medical and HemoCue in the U.S., Vidacare in the U.S. and the Netherlands. Presently he is the chairman of the board at Labex of Scandinavia, and industrial advisor to Swedish private equity fund Valedo.
Shareholding in Monivent: 128 216 shares
Mattias currently acts as Business Angel and Member of the Board in SME companies. He has 25 years experience in various roles from the technology industry, mainly Food, Pharma and Medical Device area, for both listed and unlisted companies. His last position was market area manager LifeScience for ÅF. Mattias holds M.Sc. degree in Chemical Engineering from Lunds University of Technology.
Shareholding in Monivent: 86 802 shares
Camilla Myhre Sandberg
Camilla has 21 years’ experience in life science and has a Cand. Scient degree in toxicology from the University of Oslo. She has a broad experience in business development and marketing and has previously worked at Dynal Biotech, GE Healthcare and BioLamina AB. Camilla is currently CEO of Miris Holding AB and board member of NextCell Pharma AB.
Lars has a MS in Business Administration and is an authorized financial analyst (AFA). He has extensive experience in IR and communication and has previously worked at Solberg Kommunikation, JKL and Dagens Industri and is currently Head of Investor Relations at Getinge and board member of SWESTEP.